Epidemiology of Valvular Heart Disease in Asia Pacific Region
9
Issued Date
2025-06-01
Resource Type
eISSN
27723747
Scopus ID
2-s2.0-105005412417
Journal Title
JACC: Asia
Volume
5
Issue
6
Start Page
718
End Page
743
Rights Holder(s)
SCOPUS
Bibliographic Citation
JACC: Asia Vol.5 No.6 (2025) , 718-743
Suggested Citation
So K.C.y., Yap J., Song G.y., Poon K., Sung S.H., Chandavimol M., Hayashida K., Park D.W., Ewe S.H., Chen M., Hei-tung Chan V., Iwata J., Tangcharoen T., Tern P., Park H.S., Alasnag M., Ohno Y., Hon J.K.F., Bhagwandeen R., Tabata M., Lee A.P.w., Jilaihawi H., Wang D.D., Tang G.H.L., Lim D.S., Modine T., Lam Y.y. Epidemiology of Valvular Heart Disease in Asia Pacific Region. JACC: Asia Vol.5 No.6 (2025) , 718-743. 743. doi:10.1016/j.jacasi.2025.03.011 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/110381
Title
Epidemiology of Valvular Heart Disease in Asia Pacific Region
Author's Affiliation
Ramathibodi Hospital
Juntendo Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
National University Health System
Duke-NUS Medical School
Beijing Anzhen Hospital, Capital Medical University
National Yang-Ming University Taiwan
Asan Medical Center
Tokai University School of Medicine
Keio University School of Medicine
University of Virginia
Centre Hospitalier Universitaire de Bordeaux
Cedars-Sinai Medical Center
Sinai Health System
John Hunter Hospital
The University of British Columbia
King Fahd Armed Forces Hospital
National Heart Centre Singapore
The Prince Charles Hospital
Chinese University of Hong Kong
NCH Heart Institute
Central Medical Limited
Juntendo Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
National University Health System
Duke-NUS Medical School
Beijing Anzhen Hospital, Capital Medical University
National Yang-Ming University Taiwan
Asan Medical Center
Tokai University School of Medicine
Keio University School of Medicine
University of Virginia
Centre Hospitalier Universitaire de Bordeaux
Cedars-Sinai Medical Center
Sinai Health System
John Hunter Hospital
The University of British Columbia
King Fahd Armed Forces Hospital
National Heart Centre Singapore
The Prince Charles Hospital
Chinese University of Hong Kong
NCH Heart Institute
Central Medical Limited
Corresponding Author(s)
Other Contributor(s)
Abstract
Valvular heart disease poses a significant health burden in the Asia-Pacific region, with its epidemiology varying widely across countries caused by diverse socioeconomic and health care situations. Rheumatic heart disease remains prevalent, especially in low- to middle-income areas, while degenerative valvular diseases are emerging in developed regions caused by an aging population. Significant disparities in access to health care and intervention result in variable clinical outcomes. In the past decade, transcatheter interventions have revolutionized the management of patients with valvular heart disease globally. In the Asia-Pacific region, the uptake and development of transcatheter valvular interventions has been slow until recent years. Continued collaboration across the Asia-Pacific region is essential to mitigate the impact of the upcoming surge of valvular heart disease in this diverse and rapidly changing area.